Oxford Ventures, Inc. Signs Definitive Merger Agreement To Acquire ULURU Inc.; Completes $13 Million Convertible Debenture Offering; Enters $30 Million Standby Equity Distribution Agreement

MESA, Ariz.--(BUSINESS WIRE)--Oct. 12, 2005--Oxford Ventures, Inc. (OTC Bulletin Board : OXFV.OB)("Oxford") today announced that it has signed a definitive merger agreement to acquire ULURU Inc. ("ULURU"), a private Delaware company that focuses on advanced topical delivery of pharmaceutical agents. Separately, today ULURU announced the acquisition of the topical product assets of Access Pharmaceuticals, Inc. in a transaction valued at up to $20.7 million. Attached to this press release is a copy of the ULURU press release announcing the acquisition of the topical product assets.